Pendleton Todd
SEC CIK 1746636 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DLB | Dolby Laboratories, Inc. | SVP, CMO | 41.5K | — | $13.78M | 34 | 2021-07-16 | 2026-05-22 |
Most active insiders at DLB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | YEAMAN KEVIN J | Pres, CEO, Dir | — | $8.72M |
| 2 | Couling John D | SVP, Entertainment | — | $3.82M |
| 3 | SHERMAN MARK ANDREW | EVP, Gen. Counsel, Sec | — | $1.08M |
| 4 | Revankar Shriram | SVP, Advanced Technology Group | — | $747.9K |
| 5 | Pendleton Todd | SVP, CMO | — | $647.9K |
| 6 | Nicholson Ryan | VP, CAO, Corp. Ctrl | — | $359.5K |
| 7 | Park Robert J | SVP, CFO | — | $277.4K |
| 8 | Prophet Tony A | Dir | — | $223.9K |
| 9 | Rollins Emily | Dir | — | $60.1K |
| 10 | Whitten Marc | Pres, CEO, Dir | — | — |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 17:10 | 2026-05-22 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | S - Sale | $54.55 | -11.9K | 41.5K | -22% | -$647.9K | |
| DM | 2025-12-17 | 2025-12-15+ | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | F - Tax | $67.32 | -8,015 | 53.4K | -13% | -$539.5K |
| D | 2025-12-17 | 2025-12-15 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $0.00 | +5,233 | 61.4K | +9% | $0 |
| D | 2025-12-17 | 2025-12-15 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | A - Grant | $0.00 | +18.8K | 56.1K | +51% | $0 |
| D | 2025-02-21 | 2025-02-19 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | S - Sale+OE | $83.75 | -18.1K | 37.3K | -33% | -$1.52M |
| D | 2025-02-21 | 2025-02-19 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $71.07 | +7,286 | 55.4K | +15% | +$517.8K |
| D | 2024-12-18 | 2024-12-16 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $0.00 | +4,593 | 55.8K | +9% | $0 |
| D | 2024-12-18 | 2024-12-16 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | F - Tax | $79.18 | -7,712 | 48.1K | -14% | -$610.6K |
| D | 2024-12-18 | 2024-12-16 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | A - Grant | $0.00 | +15.6K | 51.2K | +44% | $0 |
| D | 2024-03-01 | 2024-02-28 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | S - Sale+OE | $81.69 | -24.4K | 35.7K | -41% | -$1.99M |
| DM | 2024-03-01 | 2024-02-28 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $70.29 | +12.0K | 60.1K | +25% | +$845.0K |
| D | 2023-12-19 | 2023-12-15 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | A - Grant | $0.00 | +13.8K | 50.8K | +37% | $0 |
| DM | 2023-12-19 | 2023-12-15+ | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | F - Tax | $88.44 | -7,869 | 49.2K | -14% | -$695.9K |
| D | 2023-12-19 | 2023-12-15 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | — | +5,118 | 55.9K | +10% | — |
| D | 2023-09-05 | 2023-08-31 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $68.40 | +5,285 | 43.9K | +14% | +$361.5K |
| D | 2023-09-05 | 2023-08-31 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | S - Sale+OE | $84.41 | -6,889 | 37.0K | -16% | -$581.5K |
| D | 2023-02-24 | 2023-02-22 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | S - Sale+OE | $82.32 | -28.7K | 38.6K | -43% | -$2.36M |
| DM | 2023-02-24 | 2023-02-22 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $65.62 | +18.4K | 54.1K | +51% | +$1.21M |
| D | 2022-12-19 | 2022-12-16 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | — | +3,765 | 53.0K | +8% | — |
| DM | 2022-12-19 | 2022-12-15+ | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | F - Tax | $71.94 | -7,333 | 48.9K | -13% | -$527.6K |
| D | 2022-12-19 | 2022-12-15 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | A - Grant | $0.00 | +16.2K | 49.3K | +49% | $0 |
| 2022-07-19 | 2022-07-18 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | F - Tax | $73.09 | -1,513 | 36.3K | -4% | -$110.6K | |
| DM | 2022-05-20 | 2022-05-18+ | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $64.20 | +51.6K | 44.5K | New | +$3.31M |
| DM | 2022-05-20 | 2022-05-18+ | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | S - Sale+OE | $75.44 | -51.6K | 37.8K | -58% | -$3.89M |
| 2021-12-20 | 2021-12-17 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | F - Tax | $92.00 | -1,116 | 37.8K | -3% | -$102.7K | |
| DM | 2021-12-16 | 2021-12-15+ | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | F - Tax | $91.08 | -2,731 | 38.9K | -7% | -$248.7K |
| D | 2021-12-16 | 2021-12-15 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | A - Grant | $0.00 | +13.1K | 40.1K | +48% | $0 |
| DM | 2021-08-31 | 2021-08-31 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $64.06 | +4,235 | 31.2K | +16% | +$271.3K |
| DM | 2021-08-31 | 2021-08-31 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | S - Sale+OE | $98.62 | -4,235 | 28.6K | -13% | -$417.7K |
| DM | 2021-08-10 | 2021-08-06 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $64.92 | +13.8K | 32.3K | +75% | +$896.4K |
| DM | 2021-08-10 | 2021-08-06 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | S - Sale+OE | $98.35 | -13.8K | 28.6K | -33% | -$1.36M |
| DM | 2021-08-05 | 2021-08-03 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | S - Sale+OE | $100.03 | -10.1K | 28.6K | -26% | -$1.01M |
| D | 2021-08-05 | 2021-08-03 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | M - OptEx | $62.43 | +7,368 | 35.9K | +26% | +$460.0K |
| 2021-07-16 | 2021-07-16 | DLB | Dolby Laboratories, Inc. | Pendleton Todd | SVP, CMO | F - Tax | $99.82 | -1,629 | 31.3K | -5% | -$162.6K |
Purchase Sale Sale after option exercise All abbreviations